| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | keratin filament | 9.94e-05 | 97 | 52 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | FAR/SIN/STRIPAK complex | 8.06e-04 | 17 | 52 | 2 | GO:0090443 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 9.05e-04 | 18 | 52 | 2 | GO:0000159 | |
| Domain | BMP_1/tolloid-like | 2.28e-05 | 3 | 52 | 2 | IPR015446 | |
| Domain | Pecanex_C | 4.55e-05 | 4 | 52 | 2 | PF05041 | |
| Domain | Pecanex | 4.55e-05 | 4 | 52 | 2 | IPR007735 | |
| Domain | PLPL | 7.56e-05 | 5 | 52 | 2 | IPR033562 | |
| Domain | Peptidase_M12A | 1.13e-04 | 6 | 52 | 2 | IPR001506 | |
| Domain | Astacin | 1.13e-04 | 6 | 52 | 2 | PF01400 | |
| Domain | Keratin_B2_2 | 1.73e-04 | 39 | 52 | 3 | PF13885 | |
| Domain | Keratin_B2 | 1.87e-04 | 40 | 52 | 3 | PF01500 | |
| Domain | Patatin/PLipase_A2-rel | 2.70e-04 | 9 | 52 | 2 | IPR002641 | |
| Domain | PNPLA | 2.70e-04 | 9 | 52 | 2 | PS51635 | |
| Domain | Patatin | 2.70e-04 | 9 | 52 | 2 | PF01734 | |
| Domain | KAP | 5.64e-04 | 58 | 52 | 3 | IPR002494 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 5.82e-04 | 13 | 52 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 5.82e-04 | 13 | 52 | 2 | PS00125 | |
| Domain | PP2Ac | 5.82e-04 | 13 | 52 | 2 | SM00156 | |
| Domain | Acyl_Trfase/lysoPLipase | 1.01e-03 | 17 | 52 | 2 | IPR016035 | |
| Domain | EGF_CA | 1.77e-03 | 86 | 52 | 3 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 2.50e-03 | 97 | 52 | 3 | IPR018097 | |
| Domain | EGF_CA | 2.64e-03 | 99 | 52 | 3 | PS01187 | |
| Domain | Calcineurin-like_PHP_ApaH | 2.74e-03 | 28 | 52 | 2 | IPR004843 | |
| Domain | Metallophos | 2.74e-03 | 28 | 52 | 2 | PF00149 | |
| Domain | ZnMc | 2.94e-03 | 29 | 52 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 2.94e-03 | 29 | 52 | 2 | IPR006026 | |
| Domain | Metallo-depent_PP-like | 3.15e-03 | 30 | 52 | 2 | IPR029052 | |
| Domain | - | 3.15e-03 | 30 | 52 | 2 | 3.60.21.10 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.21e-03 | 106 | 52 | 3 | IPR000152 | |
| Domain | EGF_CA | 4.76e-03 | 122 | 52 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.98e-03 | 124 | 52 | 3 | IPR001881 | |
| Domain | EGF | 5.21e-03 | 126 | 52 | 3 | PF00008 | |
| Domain | CUB | 8.22e-03 | 49 | 52 | 2 | PF00431 | |
| Domain | CUB | 8.55e-03 | 50 | 52 | 2 | SM00042 | |
| Domain | - | 9.22e-03 | 52 | 52 | 2 | 2.60.120.290 | |
| Domain | CUB | 9.57e-03 | 53 | 52 | 2 | PS01180 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.93e-05 | 21 | 41 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 2.93e-05 | 21 | 41 | 3 | MM14996 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 3.38e-05 | 22 | 41 | 3 | M47919 | |
| Pathway | REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS | 1.72e-04 | 7 | 41 | 2 | M26992 | |
| Pathway | REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION | 3.66e-04 | 10 | 41 | 2 | M27176 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 3.66e-04 | 10 | 41 | 2 | MM14509 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 3.72e-04 | 118 | 41 | 4 | M713 | |
| Pathway | REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM | 5.35e-04 | 12 | 41 | 2 | M27950 | |
| Pathway | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | 6.31e-04 | 13 | 41 | 2 | M1015 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 6.31e-04 | 13 | 41 | 2 | MM14811 | |
| Pathway | WP_DOPAMINE_METABOLISM | 6.31e-04 | 13 | 41 | 2 | M39622 | |
| Pathway | REACTOME_ERKS_ARE_INACTIVATED | 6.31e-04 | 13 | 41 | 2 | M8410 | |
| Pathway | WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE | 7.35e-04 | 14 | 41 | 2 | M39840 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 7.77e-04 | 252 | 41 | 5 | MM15585 | |
| Pathway | REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS | 8.46e-04 | 15 | 41 | 2 | M27407 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 8.46e-04 | 15 | 41 | 2 | M27161 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 9.20e-04 | 66 | 41 | 3 | MM14990 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE | 9.65e-04 | 16 | 41 | 2 | M47870 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 9.65e-04 | 16 | 41 | 2 | MM14699 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 9.65e-04 | 16 | 41 | 2 | MM14541 | |
| Pathway | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | 9.65e-04 | 16 | 41 | 2 | M514 | |
| Pathway | REACTOME_KERATINIZATION | 9.89e-04 | 153 | 41 | 4 | MM15343 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.09e-03 | 17 | 41 | 2 | MM15096 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 1.09e-03 | 17 | 41 | 2 | M27083 | |
| Pathway | REACTOME_PLATELET_SENSITIZATION_BY_LDL | 1.09e-03 | 17 | 41 | 2 | M919 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.14e-03 | 71 | 41 | 3 | MM14491 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.23e-03 | 18 | 41 | 2 | M27164 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 1.23e-03 | 18 | 41 | 2 | MM14759 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.23e-03 | 18 | 41 | 2 | MM14882 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 1.28e-03 | 74 | 41 | 3 | M17386 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 1.37e-03 | 19 | 41 | 2 | M47525 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 1.37e-03 | 19 | 41 | 2 | MM14780 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.43e-03 | 289 | 41 | 5 | MM15057 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING | 1.52e-03 | 20 | 41 | 2 | M47876 | |
| Pathway | REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION | 1.84e-03 | 22 | 41 | 2 | M6768 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 1.84e-03 | 22 | 41 | 2 | M13408 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 2.03e-03 | 313 | 41 | 5 | M27867 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 2.06e-03 | 314 | 41 | 5 | M600 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 2.19e-03 | 24 | 41 | 2 | M751 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.25e-03 | 90 | 41 | 3 | M6467 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 2.37e-03 | 646 | 41 | 7 | MM14962 | |
| Pathway | PID_MYC_PATHWAY | 2.37e-03 | 25 | 41 | 2 | M139 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 2.37e-03 | 25 | 41 | 2 | MM15379 | |
| Pathway | REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | 2.37e-03 | 25 | 41 | 2 | M808 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 2.77e-03 | 27 | 41 | 2 | MM14779 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 2.97e-03 | 28 | 41 | 2 | MM15132 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 3.19e-03 | 29 | 41 | 2 | M27528 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING | 3.19e-03 | 29 | 41 | 2 | MM15253 | |
| Pathway | REACTOME_KERATINIZATION | 3.54e-03 | 217 | 41 | 4 | M27640 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 3.64e-03 | 31 | 41 | 2 | M27400 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 3.64e-03 | 31 | 41 | 2 | M27529 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING | 3.64e-03 | 31 | 41 | 2 | MM15254 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 3.64e-03 | 31 | 41 | 2 | MM15154 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 3.64e-03 | 31 | 41 | 2 | M15195 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 3.77e-03 | 702 | 41 | 7 | M746 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.77e-03 | 108 | 41 | 3 | M17034 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING | 4.12e-03 | 33 | 41 | 2 | M27526 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 4.12e-03 | 33 | 41 | 2 | MM15252 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 4.28e-03 | 113 | 41 | 3 | M16817 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 4.28e-03 | 113 | 41 | 3 | MM14783 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 4.37e-03 | 34 | 41 | 2 | M27405 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING | 4.37e-03 | 34 | 41 | 2 | M27527 | |
| Pathway | REACTOME_RAF_ACTIVATION | 4.37e-03 | 34 | 41 | 2 | M27556 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 4.37e-03 | 34 | 41 | 2 | MM15985 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 4.37e-03 | 34 | 41 | 2 | M42555 | |
| Pathway | REACTOME_RAF_ACTIVATION | 4.62e-03 | 35 | 41 | 2 | MM15271 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 4.88e-03 | 36 | 41 | 2 | MM15339 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 4.99e-03 | 239 | 41 | 4 | MM14756 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 5.15e-03 | 37 | 41 | 2 | M27641 | |
| Pubmed | An ultra-high sulfur keratin gene is expressed specifically during hair growth. | 1.97e-07 | 8 | 54 | 3 | 2465353 | |
| Pubmed | Human liver phosphatase 2A: cDNA and amino acid sequence of two catalytic subunit isotypes. | 2.37e-06 | 2 | 54 | 2 | 2837763 | |
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 2.37e-06 | 2 | 54 | 2 | 1846293 | |
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 2.37e-06 | 2 | 54 | 2 | 2555176 | |
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 2.37e-06 | 2 | 54 | 2 | 27096707 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 10543450 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11751260 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 11113010 | ||
| Pubmed | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | 2.37e-06 | 2 | 54 | 2 | 34902541 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 27421624 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 7510677 | ||
| Pubmed | Genetic analysis of the role of proteolysis in the activation of latent myostatin. | 7.09e-06 | 3 | 54 | 2 | 18286185 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 18824173 | ||
| Pubmed | The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. | 7.09e-06 | 3 | 54 | 2 | 8206937 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 10441131 | ||
| Pubmed | Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function. | 7.09e-06 | 3 | 54 | 2 | 23341017 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 8383590 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15252037 | ||
| Pubmed | 8.97e-06 | 26 | 54 | 3 | 15454262 | ||
| Pubmed | Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse. | 1.42e-05 | 4 | 54 | 2 | 21998041 | |
| Pubmed | Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. | 1.42e-05 | 4 | 54 | 2 | 9770493 | |
| Pubmed | Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. | 1.42e-05 | 4 | 54 | 2 | 7616230 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 9920888 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 11371618 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 21454489 | ||
| Pubmed | Migratory properties of pulmonary dendritic cells are determined by their developmental lineage. | 1.42e-05 | 4 | 54 | 2 | 23168837 | |
| Pubmed | The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic. | 1.42e-05 | 4 | 54 | 2 | 14633983 | |
| Pubmed | Genetic variance in the adiponutrin gene family and childhood obesity. | 2.36e-05 | 5 | 54 | 2 | 19390624 | |
| Pubmed | HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint. | 2.36e-05 | 5 | 54 | 2 | 9009195 | |
| Pubmed | Protein phosphatase 2A interacts with and directly dephosphorylates RelA. | 2.36e-05 | 5 | 54 | 2 | 11591705 | |
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 10640627 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 10479448 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 18596935 | ||
| Pubmed | Inflammation induces two types of inflammatory dendritic cells in inflamed lymph nodes. | 2.36e-05 | 5 | 54 | 2 | 29546878 | |
| Pubmed | 2.65e-05 | 37 | 54 | 3 | 11279113 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 10781942 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 24632372 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 20100830 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 29735529 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 9647778 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 15147202 | ||
| Pubmed | STRIPAK components determine mode of cancer cell migration and metastasis. | 3.54e-05 | 6 | 54 | 2 | 25531779 | |
| Pubmed | Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis. | 3.89e-05 | 42 | 54 | 3 | 29028833 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 10698523 | ||
| Pubmed | Protein phosphatase 2A and separase form a complex regulated by separase autocleavage. | 4.94e-05 | 7 | 54 | 2 | 17604273 | |
| Pubmed | The ubiquitin E3 ligase NOSIP modulates protein phosphatase 2A activity in craniofacial development. | 4.94e-05 | 7 | 54 | 2 | 25546391 | |
| Pubmed | X-linked microtubule-associated protein, Mid1, regulates axon development. | 4.94e-05 | 7 | 54 | 2 | 24194544 | |
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 1330687 | ||
| Pubmed | Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. | 6.59e-05 | 8 | 54 | 2 | 11007961 | |
| Pubmed | Cytosolic Arl2 is complexed with cofactor D and protein phosphatase 2A. | 6.59e-05 | 8 | 54 | 2 | 12912990 | |
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 16262633 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 35768646 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 12370081 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 23462102 | ||
| Pubmed | 8.46e-05 | 9 | 54 | 2 | 18432318 | ||
| Pubmed | 8.46e-05 | 9 | 54 | 2 | 12885400 | ||
| Pubmed | 8.46e-05 | 9 | 54 | 2 | 19029121 | ||
| Pubmed | Dendritic Cells Coordinate the Development and Homeostasis of Organ-Specific Regulatory T Cells. | 8.46e-05 | 9 | 54 | 2 | 27037189 | |
| Pubmed | Characterization of the human patatin-like phospholipase family. | 1.06e-04 | 10 | 54 | 2 | 16799181 | |
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 11842093 | ||
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 22442484 | ||
| Pubmed | 1.55e-04 | 12 | 54 | 2 | 11259605 | ||
| Pubmed | 1.55e-04 | 12 | 54 | 2 | 21029863 | ||
| Pubmed | 1.55e-04 | 12 | 54 | 2 | 34079065 | ||
| Pubmed | 1.55e-04 | 12 | 54 | 2 | 12435421 | ||
| Pubmed | 1.72e-04 | 69 | 54 | 3 | 18721477 | ||
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 18971272 | ||
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 21072166 | ||
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 16717086 | ||
| Pubmed | Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. | 2.13e-04 | 14 | 54 | 2 | 9013886 | |
| Pubmed | 2.13e-04 | 14 | 54 | 2 | 9400615 | ||
| Pubmed | The non-canonical Wnt-PCP pathway shapes the mouse caudal neural plate. | 2.45e-04 | 15 | 54 | 2 | 29636380 | |
| Pubmed | 2.45e-04 | 15 | 54 | 2 | 38474134 | ||
| Pubmed | 2.80e-04 | 16 | 54 | 2 | 32895539 | ||
| Pubmed | 2.80e-04 | 16 | 54 | 2 | 23047923 | ||
| Pubmed | 3.17e-04 | 17 | 54 | 2 | 17266553 | ||
| Pubmed | [Action of protein phosphatase-1 on Tat-dependent HIV-1 transcription and its related inhibitors]. | 3.17e-04 | 17 | 54 | 2 | 21351466 | |
| Pubmed | 3.56e-04 | 18 | 54 | 2 | 23287597 | ||
| Pubmed | A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. | 3.56e-04 | 18 | 54 | 2 | 16085932 | |
| Pubmed | 3.98e-04 | 19 | 54 | 2 | 32582689 | ||
| Pubmed | Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation. | 3.98e-04 | 19 | 54 | 2 | 26389696 | |
| Pubmed | Shugoshin collaborates with protein phosphatase 2A to protect cohesin. | 3.98e-04 | 19 | 54 | 2 | 16541025 | |
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 21514445 | ||
| Pubmed | Palmitoyl acyltransferase Aph2 in cardiac function and the development of cardiomyopathy. | 5.86e-04 | 23 | 54 | 2 | 26644582 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.03e-04 | 248 | 54 | 4 | 24006456 | |
| Pubmed | 6.94e-04 | 25 | 54 | 2 | 34004147 | ||
| Pubmed | 6.97e-04 | 111 | 54 | 3 | 12508121 | ||
| Pubmed | 7.51e-04 | 26 | 54 | 2 | 11531413 | ||
| Pubmed | Genetic variations in humans associated with differences in the course of hepatitis C. | 1.14e-03 | 32 | 54 | 2 | 15063762 | |
| Pubmed | 1.21e-03 | 33 | 54 | 2 | 19817957 | ||
| Pubmed | 1.36e-03 | 35 | 54 | 2 | 32281291 | ||
| Pubmed | 1.44e-03 | 36 | 54 | 2 | 22422068 | ||
| Pubmed | Control of APC/C-dependent ubiquitin chain elongation by reversible phosphorylation. | 1.52e-03 | 37 | 54 | 2 | 26811472 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.54e-03 | 1105 | 54 | 7 | 35748872 | |
| Interaction | TFAP2D interactions | 3.31e-06 | 89 | 52 | 5 | int:TFAP2D | |
| Interaction | GNE interactions | 7.12e-06 | 104 | 52 | 5 | int:GNE | |
| Interaction | LCE3E interactions | 1.73e-05 | 60 | 52 | 4 | int:LCE3E | |
| Interaction | LCE3C interactions | 2.68e-05 | 67 | 52 | 4 | int:LCE3C | |
| Interaction | NTN4 interactions | 2.77e-05 | 23 | 52 | 3 | int:NTN4 | |
| Interaction | CDC20 interactions | 2.99e-05 | 234 | 52 | 6 | int:CDC20 | |
| Interaction | NR4A3 interactions | 3.01e-05 | 69 | 52 | 4 | int:NR4A3 | |
| Interaction | MAPKBP1 interactions | 3.97e-05 | 74 | 52 | 4 | int:MAPKBP1 | |
| Interaction | OTX1 interactions | 4.90e-05 | 155 | 52 | 5 | int:OTX1 | |
| Interaction | RGL2 interactions | 5.07e-05 | 28 | 52 | 3 | int:RGL2 | |
| Interaction | CREB5 interactions | 6.41e-05 | 164 | 52 | 5 | int:CREB5 | |
| Interaction | LCMT1 interactions | 8.37e-05 | 33 | 52 | 3 | int:LCMT1 | |
| Interaction | KRTAP9-4 interactions | 8.37e-05 | 33 | 52 | 3 | int:KRTAP9-4 | |
| Interaction | NIF3L1 interactions | 8.71e-05 | 175 | 52 | 5 | int:NIF3L1 | |
| Interaction | NUFIP2 interactions | 9.25e-05 | 417 | 52 | 7 | int:NUFIP2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 2.37e-04 | 473 | 54 | 5 | chr17q21 | |
| Cytoband | 17q12-q21 | 6.58e-04 | 32 | 54 | 2 | 17q12-q21 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 7.48e-05 | 6 | 41 | 2 | 894 | |
| GeneFamily | Patatin like phospholipase domain containing | 2.23e-04 | 10 | 41 | 2 | 466 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 3.85e-04 | 13 | 41 | 2 | 693 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 9.29e-04 | 20 | 41 | 2 | 1371 | |
| GeneFamily | Keratin associated proteins | 1.92e-03 | 109 | 41 | 3 | 619 | |
| GeneFamily | Olfactory receptors, family 52 | 5.52e-03 | 49 | 41 | 2 | 165 | |
| GeneFamily | LIM domain containing | 7.91e-03 | 59 | 41 | 2 | 1218 | |
| GeneFamily | Ring finger proteins | 2.43e-02 | 275 | 41 | 3 | 58 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 1.72e-06 | 184 | 52 | 6 | M8544 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP | 1.95e-06 | 188 | 52 | 6 | MM983 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 2.88e-05 | 30 | 52 | 3 | M47990 | |
| Coexpression | GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | 4.78e-05 | 200 | 52 | 5 | M8693 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.69e-05 | 129 | 53 | 4 | 6a201c6344a015e5cf2f79ccf397fd7ad66b6768 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-05 | 132 | 53 | 4 | f8e2ba53063007d7507f1837ad669b0e4333cd23 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.75e-05 | 146 | 53 | 4 | 522c32103c24fc26836bb5b642083904682d9292 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 155 | 53 | 4 | f3489a548a2c0cc2d9117ff85865c6089ea0835d | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 155 | 53 | 4 | 0e24e767a3895d31d34cabeaca0354aadae34e44 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-05 | 169 | 53 | 4 | a83e4078db91ecedee637b28b12ec38640fe45f9 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-05 | 169 | 53 | 4 | f914aa8899fa170a09da31e5fad86de897ea789b | |
| ToppCell | control-Myeloid-Monocyte-derived_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.10e-05 | 171 | 53 | 4 | e828b684744a4fdf6b63ec033c4f000b39ca0d51 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-05 | 172 | 53 | 4 | 48d0cfc37d1b1ae48ed8f8b2711abeb609d2bb6e | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 172 | 53 | 4 | 7c085c02b59e24e2a2cd393b5e692f9fb19257fe | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-05 | 172 | 53 | 4 | c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f | |
| ToppCell | NS-control-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.46e-05 | 174 | 53 | 4 | 758984730cd1c3ccf6866a3a8f03d6e002f3edb6 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.71e-05 | 176 | 53 | 4 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 6.64e-05 | 183 | 53 | 4 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 6.64e-05 | 183 | 53 | 4 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.99e-05 | 192 | 53 | 4 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_only / Treatment groups by lineage, cell group, cell type | 9.00e-05 | 198 | 53 | 4 | 53c22e81e530d6fc272d4a45c8d1bf125feb254d | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.00e-05 | 198 | 53 | 4 | 436f3a9ef31b0991765bb97c21960f20fa71d578 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.00e-05 | 198 | 53 | 4 | ba3b97bb3e1533df758e845bde7d82eb1525b057 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.36e-05 | 200 | 53 | 4 | f78968d4b4d907094b2c44dcf5ac557ae94e4484 | |
| Disease | Chanarin-Dorfman syndrome (implicated_via_orthology) | 3.87e-05 | 6 | 48 | 2 | DOID:0050729 (implicated_via_orthology) | |
| Disease | Anhedonia | 6.99e-04 | 24 | 48 | 2 | C0178417 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CIYVPCQCFAVGFLK | 31 | Q9BZS9 | |
| ARLCVYPYYTATCCR | 1046 | Q6UY14 | |
| CYILLGGVFLCYCMT | 606 | Q14416 | |
| CVRCCVNPFLYAFIG | 316 | P32248 | |
| CYNCISDCPNLRVYF | 16 | P11844 | |
| CEPLPYYTCSCVLGF | 716 | P51828 | |
| GIFVICCLTYCFAPR | 256 | P33681 | |
| IVFTYRPCGCCSYVG | 176 | P13497 | |
| ICYPLCGFVILAACV | 71 | O75071 | |
| CGVVCKYFQRGCCVY | 121 | Q13434 | |
| CCPFIFLVYRLTYCG | 141 | P0C646 | |
| FCIQLPLICGTYYFT | 106 | Q15800 | |
| CYVAICDPLCYTLVL | 121 | Q8NGJ3 | |
| LYCGPCHIAYFFCDI | 181 | Q8NGN2 | |
| VYCERCYEQFFAPLC | 596 | O75112 | |
| RCCISAAPYRGVSCY | 31 | P78386 | |
| HCRGLVTVKPCYNYC | 256 | O75487 | |
| IIAYSRPVYFCICCG | 1066 | Q96RV3 | |
| YSRPVYFCICCLLIW | 856 | Q9H6A9 | |
| EALYCSCFVPVYCGL | 146 | Q8N8W4 | |
| VVTIFSAPNYCYRCG | 256 | P62714 | |
| VVTIFSAPNYCYRCG | 256 | P67775 | |
| RPFCCGCFESLYAEY | 236 | Q96MT3 | |
| CTLSGPIYLIFEYCC | 681 | P36888 | |
| FYTYPVAIRCDCGAC | 106 | Q86YW7 | |
| PVGVVCYRVYCCCCL | 266 | A4D1U4 | |
| RCINRVGSYSCFCYP | 901 | Q14767 | |
| IFYISCPQNPYCVCF | 266 | P32245 | |
| VLYCGVCSLPTEYCE | 31 | O43583 | |
| CFVECAPVCYTETCY | 131 | Q5T749 | |
| CAPVYCRRTCYYPTT | 111 | Q9BYQ4 | |
| CAPVYCRRTCYYPTT | 96 | Q9BYQ2 | |
| CAPVYCRRTCYYPTT | 91 | Q9BYP9 | |
| IAAFYGCLYCGCVPV | 1056 | Q14689 | |
| CQVTGCQCRAYLYVP | 101 | A4D161 | |
| RASFVTCPCCYGFIQ | 531 | Q8NEC7 | |
| VFQVCIGCFLCYCPG | 971 | P20648 | |
| ICAVCLDVYFNPYMC | 431 | Q86T96 | |
| GVRYQCSLCPSYNIC | 226 | Q14596 | |
| IQALVCTLYFPFYCG | 141 | Q7Z6Z6 | |
| CFPCVGYSVPFCYVN | 1021 | Q8IZU2 | |
| YSMYCVSCRTPVCYL | 311 | Q6ZTA4 | |
| GYIYPRLYCLFAECC | 36 | O14656 | |
| LCGYVYALRVERFCC | 316 | Q6IEE8 | |
| VFSYRTCGCCSYVGR | 206 | Q9Y6L7 | |
| VFLYTLGCVCAACLY | 136 | Q9Y5Z9 | |
| LGCVCAACLYYLSPL | 141 | Q9Y5Z9 | |
| PSVLVGYFCCYCHFS | 436 | Q96BW9 | |
| RVCAACTVTYYCGVV | 26 | Q9H0C1 | |
| LIICCLCGSGYLIYF | 436 | Q8TDI7 | |
| FCYALICSIPVFTYI | 921 | Q5H8A4 | |
| LEIPTGPRCYSCYVC | 181 | Q6IV72 | |
| GPRCYSCYVCRKVFQ | 186 | Q6IV72 | |
| RECFTGYRQLCGCYL | 391 | Q9NVH6 | |
| PLFSYIVERLCACCY | 1136 | Q9Y4A5 | |
| ICFTTCCVYRPLKFR | 341 | Q9NQA5 | |
| FCYLCFVSIYGLTCL | 321 | Q8TDW0 |